|
District of Columbia Center for AIDS Research (CFAR), AIDS Prevention Center (APC), and D.C. Department of Health (DOH) Continuum of Care Working Group Meeting
|
Meeting/ Workshop
|
CDC
|
NIAID, NICHD, NIDA, NIMH
|
The Center for AIDS Research (CFAR), AIDS Prevention Centers (APC), and D.C. Department of Health (DOH) working group meetings provide a forum for networking and collaboration for CFAR, DOH, and NIMH-supported AIDS Prevention Center (APC) investigators, as well as a platform for the presentation of progress and results of the NIH supported HIV Continuum of Care research projects.
|
|
Dominantly Inherited Alzheimer''s Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset of Dominantly Inherited Alzheimer''s Disease
|
Research Initiative
|
FDA
|
NIA
|
This collaboration aims to set up an international network consisting of a consortium of scientific investigators that will have the responsibility to identify, recruit, evaluate, and follow-up individuals from families with early onset dominantly inherited Alzheimer’s Disease [i.e., families with the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) mutations or duplications or others still to be discovered].
|
|
Drug Induced Liver Injury Network (DILIN)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDDK
|
Both a prospective and retrospective database containing cases of drug-induced liver disease, the Drug Induced Liver Injury Network (DILIN) is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. One of the goals of the DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. The DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Three employees of FDA serve as ad hoc members on the committee overseeing the network activities.
|
|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC
|
NIDCD
|
This collaboration focuses on a teleconference sponsored by CDC.
|
|
Early Learning Interagency Policy Board (IPB)
|
Other
|
ACF
|
NICHD, NIDA
|
The purpose of this workgroup is to collaborate with the Administration for Children and Families (ACF) in order to coordinate efforts in the area of preschool education, including research.
|
|
East Asia Viral Hepatitis and Liver Cancer Consortium
|
Other
|
CDC
|
NCI, NIAID, NIDDK
|
The consortium aims to coordinate and share human, financial, and technical resources to effectively and efficiently address research and public health action needs in the prevention and control of viral hepatitis and liver cancer. This is a trans-HHS collaboration working with the World Health Organization Western Pacific Region Office WHO/WPRO and Ministries of Health of several partner countries.
|
|
Ebola Clinical Research Response in West Africa
|
Research Initiative
|
CDC, FDA
|
NIAID
|
Research collaborations to respond to Ebola emergency in West Africa
|
|
Electronic Research Administration (eRA)
|
Other
|
AHRQ, CDC, FDA, SAMHSA
|
NINR, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/OER
|
The Electronic Research Administration (eRA) provides information technology solutions and support for the full life cycle of grants administration functions for the NIH as well as the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Veterans Health Administration (VHA). eRA offers vital solutions to manage the receipt, processing, review, award and monitoring of over $30 billion in research and non¬research grants awarded annually by NIH and other grantor agencies in support of the collective mission of improving human health. eRA helps NIH meet a vital mission: the support of cutting¬ edge biomedical research via grants to scientists at universities and other research institutions. Over 4,100 NIH staff, 729 partner agency staff, and 171,083 active external users depend on eRA daily. Used by Federal staff and applicants at over 28,400 research institutions worldwide, eRA has helped eliminate the hundreds of millions of pieces of paper previously required to: • Record, review and process over 89,600 applications each year. • Support more than 3,960 review meetings held annually. • Administer more than 61,200 awarded competing and non¬competing grants. • Maintain patent and invention records for 32 Federal agencies (see the iEdison website). • Support thousands of applicant interactions with the Federal Government before and after the grant award, through the eRA online interface. eRA''s focus is on supporting the mission of serviced agencies by providing tools to electronically manage and report on grants in a way that maximizes efficiencies, provides a strong and scalable infrastructure, is responsive to evolving customer needs and employs sound management controls. eRA systems align with Grants.gov (the one¬ stop web portal for finding and applying for federal grants), allowing for full electronic processing of grant applications from application submission through closeout of the grant award and reporting thereafter. eRA operates as a fee for service activity to OPDivs and other federal agencies.
|
|
Emergency Care Research Interagency Program Officer Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NICHD, FIC, NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NIDDK, NIGMS, NIMH, NINDS, NLM
|
This working group aims to share common challenges in conducting emergency care research, identify innovative solutions amongst the projects in NIH Institutes/Centers portfolios for common problems; discuss performance evaluation of emergency care networks; and discuss models for funding and evaluating data coordinating centers.
|
|
Emergency Preparedness, Medical Countermeasures
|
Resource Development
|
OS
|
NCI
|
NCI provides expertise in radiation biology and radiation oncology to help guide the research and development for medical countermeasures for radiation injury and for biomarkers for assessing injury, dose and who needs treatment.
|